Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.

Saved in:
Bibliographic Details
Title: Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
Authors: Siegmund HU; Bayer Technology Services GmbH, Leverkusen, Germany., Burghaus R; Bayer Pharma AG, Wuppertal, Germany., Kubitza D; Bayer Pharma AG, Wuppertal, Germany., Coboeken K; Bayer Technology Services GmbH, Leverkusen, Germany.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2015 Jun; Vol. 79 (6), pp. 959-66.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2125
DOI:10.1111/bcp.12571